Patents by Inventor Xinghang Ma

Xinghang Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230190637
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: November 11, 2020
    Publication date: June 22, 2023
    Inventors: Jun XIANG, Xinghang MA
  • Publication number: 20210077381
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: November 11, 2020
    Publication date: March 18, 2021
    Inventors: Jun XIANG, Xinghang MA
  • Publication number: 20180055940
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: August 16, 2017
    Publication date: March 1, 2018
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Xinghang MA, Jun XIANG
  • Publication number: 20180028669
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: October 18, 2017
    Publication date: February 1, 2018
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Jun XIANG, Xinghang MA
  • Patent number: 9849181
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: December 26, 2017
    Inventors: Jun Xiang, Xinghang Ma
  • Patent number: 9592297
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 14, 2017
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Jun Xiang, Xinghang Ma
  • Publication number: 20170008965
    Abstract: Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Application
    Filed: September 27, 2016
    Publication date: January 12, 2017
    Inventors: Xinghang MA, Jun XIANG, Jianjie NIU
  • Publication number: 20160030524
    Abstract: Provided are liquid and lyophilized recombinant Factor VIII formulations, including formulations for polymer-conjugated FVIII such as PEGylated Factor VIII.
    Type: Application
    Filed: March 11, 2014
    Publication date: February 4, 2016
    Applicant: BAYER HEALTHCARE LLC
    Inventors: De Qian WANG, Xinghang MA, Nelly TSVETKOVA
  • Publication number: 20160002342
    Abstract: Provided are a wide concentration range, especially high concentration anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 7, 2016
    Inventors: Xinghang MA, Jianjie NIU
  • Publication number: 20150252116
    Abstract: Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Application
    Filed: August 28, 2013
    Publication date: September 10, 2015
    Inventors: Xinghang Ma, Jun Xiang, Jianjie Niu
  • Publication number: 20150209431
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: August 28, 2013
    Publication date: July 30, 2015
    Inventors: Xinghang Ma, Jun Xiang
  • Patent number: 9023357
    Abstract: Provided are a wide concentration range, especially high concentration anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: May 5, 2015
    Assignee: Bayer HealthCare LLC
    Inventors: Xinghang Ma, Jianjie Niu
  • Publication number: 20150093393
    Abstract: Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Application
    Filed: September 30, 2014
    Publication date: April 2, 2015
    Inventors: Xinghang Ma, Jun Xiang, Jianjie Niu
  • Publication number: 20150030591
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: August 12, 2014
    Publication date: January 29, 2015
    Inventors: Jun Xiang, Xinghang Ma
  • Patent number: 8883979
    Abstract: Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 11, 2014
    Assignee: Bayer HealthCare LLC
    Inventors: Xinghang Ma, Jun Xiang, Jianjie Niu
  • Publication number: 20140274902
    Abstract: Provided are liquid and lyophilized rFVIII formulations, including full-length rFVIII (FL-rFVIII) formulations, B-domain deleted rFVIII (BDD-rFVIII) formulations, and BDD-rFVIII mutant (BDD-rVIII mutant) formulations. Also provided are liquid and lyophilized PEGylated rFVIII (PEG-rFVIII) formulations, including PEGylated full-length rFVIII (PEG-FL-rFVIII) formulations, PEGylated B-domain deleted rFVIII (PEG-BDD-rFVIII) formulations, and PEGylated BDD-rFVIII mutant (PEG-BDD-rFVIII mutant) formulations.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: BAYER HEALTHCARE, LLC
    Inventors: Deqian Wang, Xinghang Ma, Nelly Tsvetkova
  • Publication number: 20140271659
    Abstract: Provided are a wide concentration range, especially high concentration anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: Bayer HealthCare LLC
    Inventors: XINGHANG MA, JIANJIE NIU
  • Publication number: 20140105892
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: December 16, 2013
    Publication date: April 17, 2014
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Jun Xiang, Xinghang Ma
  • Publication number: 20140065158
    Abstract: Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 6, 2014
    Inventors: Xinghang Ma, Jun Xiang, Jianjie Niu
  • Publication number: 20140065159
    Abstract: Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 6, 2014
    Inventors: Xinghang Ma, Jun Xiang